Injection of the insulin receptor alpha subunit increases blood glucose levels in mice. 2003

Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
Division of Molecular Genetics, Institutes for Enzyme Research, The University of Tokushima, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.

Using the expression vector of the truncated human insulin receptor (hIR), we have constructed a stable Chinese hamster ovary (CHO) cell line which secretes the His-tagged alpha subunit (insulin-binding domain) of hIR into medium. To examine characteristics of the His-tagged hIRalpha, we purified the protein secreted from the CHO cells. The His-tagged hIRalpha was glycosylated and processed a dimer. The molecule bound insulin with an affinity similar to that of the intact hIR. The His-tagged full length of hIR was autophosphorylated by insulin stimulation in CHO cells. Injection of the purified His-tagged hIRalpha into veins of mice increased in the concentration of blood glucose within 30 min. The intraperitoneal glucose tolerance test (ipGTT) done after injection of the purified His-tagged hIRalpha showed evidence of a marked hyperglycemia. These findings provide direct evidence that the presence of hIRalpha in the blood stream inhibits insulin actions by binding with plasma insulin.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
January 1988, Advances in experimental medicine and biology,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
March 1984, Research communications in chemical pathology and pharmacology,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
May 2024, Heliyon,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
September 1989, The Journal of biological chemistry,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
September 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
January 2008, European journal of pharmacology,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
January 2008, Journal of cellular and molecular medicine,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
March 2017, Proceedings of the National Academy of Sciences of the United States of America,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
May 2012, FEBS letters,
Yoshiko Kanezaki, and Rie Matsushima, and Toshiyuki Obata, and Yutaka Nakaya, and Toshio Matsumoto, and Yousuke Ebina
January 1981, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Copied contents to your clipboard!